What You Need to Know An expert explains how the new program, which launches July 1, will work and who is eligible NEED TO KNOW Key Takeaways A new Medicare pilot program will offer GLP-1 weight-loss medications for $50 a month starting July 1 The program, which runs for 18 months, covers over 14 million eligible beneficiaries who have been diagnosed as obese or overweight Learn more about what to expect, who qualifies and how to maximize the benefits from a medical expert Beginning July 1, millions of Americans on Medicare will have access to GLP-1 weight-loss drugs for just $50 a month
They're like the backstage crew that keeps everything running smoothly
After the addition of GLP-1 and exendin-4, respectively, the contraction curve was recorded within 5 min
Upcoming Giants (in people being less giant) Although there are many other GLP1R agonists in the pipeline across many companies, some of the few standout drugs, in terms of body weight loss efficacy, are worth noting in brief
Novo Nordisk launched the product in the United States in January 2026, marking the first time an oral GLP-1 treatment had been cleared specifically for weight management